Transfer-pricing benchmarking favours TNMM where no reliable uncontrolled comparable exists and transaction characteristics materially differ.
Transfer-pricing and depreciation issues concerning acquired intangibles, non-compete payments, associated-enterprise status, operating margins and interest on ICCDs are addressed. The notes describe TNMM as preferable to CUP where no valid comparable uncontrolled transaction exists and transaction characteristics differ. They also address dominant influence amounting to de facto control for deemed associated-enterprise status, exclusion of abnormal goodwill amortisation from operating expenditure, continued inclusion of ordinary depreciation, recomputation of written-down value for intangible assets, and fresh verification of interest benchmarking on ICCDs.
Issues: (i) Whether depreciation on acquired intangible assets and non-compete fee should be allowed; (ii) Whether CUP or TNMM was the most appropriate method for benchmarking sales to associated enterprises; (iii) Whether Apotex entities were deemed associated enterprises under section 92A(2)(i); (iv) Whether amortisation of goodwill and depreciation required adjustment in computing operating margins under TNMM; (v) Whether the transfer-pricing adjustment on interest paid on ICCDs required recomputation.
Issue (i): Whether depreciation on acquired intangible assets and non-compete fee should be allowed.
Analysis: The assessment order for the preceding year, pursuant to which depreciation had been allowed, was held time-barred. The written-down value of the intangible assets consequently required recomputation in accordance with the earlier Tribunal directions.
Conclusion: The depreciation claim was remitted for recomputation of the written-down value and allowance of depreciation in accordance with law, in favour of the assessee.
Issue (ii): Whether CUP or TNMM was the most appropriate method for benchmarking sales to associated enterprises.
Analysis: A CUP requires an actual price in a comparable uncontrolled transaction. The legacy agreements were agreements involving the associated enterprises and could not constitute an internal CUP. The Northstar arrangement was not comparable because it operated in a different segment. Given the numerous transactions, substantial variations from agreement prices, and the nature and class of transactions, TNMM was appropriate.
Conclusion: Rejection of CUP and adoption of TNMM as the most appropriate method was upheld, against the assessee.
Issue (iii): Whether Apotex entities were deemed associated enterprises under section 92A(2)(i).
Analysis: The preceding-year decision applied the requirement that influence under section 92A(2)(i) must amount to dominant influence resulting in de facto control. Apotex entities accounted for more than one-fifth of the assessee's sales and were capable of exercising such dominant influence.
Conclusion: Apotex entities were correctly treated as deemed associated enterprises, against the assessee.
Issue (iv): Whether amortisation of goodwill and depreciation required adjustment in computing operating margins under TNMM.
Analysis: Amortisation of goodwill arising from the business acquisition was an abnormal item and did not form part of operating expenditure. Ordinary depreciation, however, was not extraordinary and had been considered for both the assessee and comparables while determining margins.
Conclusion: Goodwill amortisation must be excluded from operating expenditure, in favour of the assessee; exclusion of depreciation was rejected, against the assessee.
Issue (v): Whether the transfer-pricing adjustment on interest paid on ICCDs required recomputation.
Analysis: The interest adjustment followed the approach adopted for the preceding year, where the comparability of an instrument used by the TPO required fresh verification. The issue therefore required reconsideration under the earlier directions.
Conclusion: The interest adjustment was remitted to the Assessing Officer/TPO for fresh computation in accordance with law, in favour of the assessee.
Final Conclusion: The transfer-pricing method and deemed-AE findings stand, while depreciation, goodwill-amortisation and ICCD-interest matters receive the specified relief or fresh determination.